PPT-PERINATAL OUTCOMES IN STAGE II FETAL GROWTH RESTRICTION

Dr Nibedita Maharana Dr Sweta Singh Dr Jasmina Begum Dr Subarna Mitra Department of Obstetrics and Gynaecology All India Institute of Medical Sciences Bhubaneswar INTRODUCTION. fetal livers from normal and deformed specimenswere performed and those results are reported and compared.Skeletal deformitiesof the fetusesincluded, but werenot limited to, twistedand shortlimbs,swol Eric H. Dellinger, MD. Greenville Hospital System. IUGR: Introduction. IUGR 2nd leading contributor to PNM rate. PNM rate increased 6-10 fold. PNM rate 8/1000 background:. 120/1000 for all IUGR. 60-80/1000 when anomalies excluded. Conrad R. Chao, MD. Professor of Obstetrics and Gynecology. Chief of Maternal and Fetal Medicine. University of New Mexico. What is FGR. SGA = birthweight below 10. th. percentile. Associated with higher morbidity, mortality, and subsequent adult disease (Barker hypothesis). (PSIP). Design and Development of a Perinatal Safety Intervention . Program. Agency for Healthcare Research and Quality (AHRQ) contract has been awarded to Partners Promoting Perinatal Safety (P3S), a partnership between RTI International, Vanderbilt University, and the University of North Carolina—the opportunity to bring our considerable experience in patient safety interventions and perinatal care to this . kkk. Kkk . . The objective of this systematic review is to identify, evaluate and synthesise the available evidence for the advantages of using Fetal Renal Artery Doppler, Middle Cerebral Artery Doppler and Ductus Venosus Doppler in those pregnancies complicated by intrauterine growth restriction. . (CTG). Dr Reza Nasr MD MRCOG DFFP. Consultant in Obstetrics and Gynaecology. University . of London. First Fetal Heart Monitoring. Today’s fetal heart monitoring. Why is it called . CTG. ?. C. ardio. Lindsay Mayet Lasseigne. LSU School of Medicine, Class of 2014. September 13, 2013. Objectives. Discuss the basics of MMC. Overview of the MOMS Trials. Overview of the Endoscopic Trials. Summarize controversies of fetal repair. chorionicity. in twin gestations. Society of Maternal Fetal Medicine with the assistance . of . Kenneth J. . Moise. Jr. MD, Pedro S. . Argotti. MD . Published in . Contemporary OB/GYN / Feb 2013. Incidence. Effects of intrauterine retention and postmortem interval on body weight following intrauterine death: implications for assessment of fetal growth restriction at . autopsy. J Man, JC Hutchinson, M Ashworth, AE Heazell, S Levine and NJ Sebire . Dr . Soraya. . Saleh. . Gargari. Fellowship . feto. - maternal medicine. Shahid. . Beheshti. university. . At end of this lecture you should be able to:. . describe IUGR. . possible . etiologies. Phases . of fetal growth. First 16 weeks:. mostly cellular hyperplasia. 16-32 weeks:. both hyperplasia and hypertrophy. >32 weeks:. mostly hypertrophy. Thus: early growth restriction will affect cell numbers and have a global (symmetrical IUGR) effect. Later cell size will be affected (asymmetrical IUGR). Venosus. Doppler. Insights from the Trial of Umbilical and Fetal Flow in . Europe. Tiziana FRUSCA, MD. 1*. ; Tullia TODROS, MD. 2*. , Christoph LEES, MD. 3,4. ; Caterina M. BILARDO, MD. 5. ; . and TRUFFLE Investigators. Dr.. KAVITA MAKASARE. JR III. DEFINITION. CAUSES. PATHOPHYSIOLOGY. TYPES. INVESTIGATION: BIOMETRY. DOPPLER. MANAGEMENT. IUGR. a . fetus. is growth-retarded if its weight is. Dr Matthew Chico (LSHTM) and Prof Asma Khalil (SGUL). Email: . akhalil@sgul.ac.uk. . Email: . matthew.chico@lshtm.ac.uk. . Prof Asma Khalil. Background. Expert in . fetal. medicine, multiple (twin) pregnancy, prenatal screening, prenatal diagnosis, chorionic villus sampling, amniocentesis, obstetric ultrasound, Doppler assessment, .